Argeris N. Karabelas, Chairman of the Board at Vanda Pharmaceuticals Inc. (VNDA), sold 300,000 shares at $14.12 ($4.2M) on 2006-11-22, disclosed to the SEC on 2006-11-27.
Open-market sale of $4.2M VNDA by Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.12 | 19,260 | $272K | 6.4% |
| 2 | $14.12 | 280,740 | $4.0M | 93.6% |
| Total | $14.12 avg | 300,000 | $4.2M | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |